Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.34
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.78B | 2.66B | 3.09B | 2.19B | 2.53B |
| Total Other Revenue | -17.26M | 17.08M | -- | 29.79M | -14.41M |
| Total Revenue | 2.76B | 2.68B | 3.09B | 2.21B | 2.52B |
| Cost of Revenue | 2.32B | 2.26B | 2.46B | 1.93B | 2.14B |
| Gross Profit | 446.57M | 420.30M | 633.76M | 280.60M | 373.38M |
| SG&A Expenses | 271.34M | 286.97M | 314.13M | 275.84M | 235.19M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -6.56M | 14.15M | 2.95M | 22.62M | 4.05M |
| Total Operating Expenses | 2.60B | 2.58B | 2.79B | 2.26B | 2.41B |
| Operating Income | 159.66M | 99.59M | 296.93M | -43.61M | 107.97M |
| Income Before Tax | 152.80M | 118.85M | 306.72M | -55.39M | 108.49M |
| Income Tax Expenses | 37.93M | 19.49M | 51.36M | -15.26M | 21.68M |
| Earnings from Continuing Operations | 114.87M | 99.36M | 255.37M | -40.14M | 86.80M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.95M | -3.27M | -4.97M | -4.83M | -1.68M |
| Net Income | 110.92M | 96.09M | 250.40M | -44.97M | 85.13M |
| EBIT | 159.66M | 99.59M | 296.93M | -43.61M | 107.97M |
| EBITDA | 180.42M | 120.99M | 317.36M | -22.96M | 131.20M |
| EPS Basic | 0.07 | 0.06 | 0.15 | -0.03 | 0.05 |
| Normalized Basic EPS | 0.06 | 0.04 | 0.12 | -0.02 | 0.04 |
| EPS Diluted | 0.07 | 0.06 | 0.15 | -0.03 | 0.05 |
| Normalized Diluted EPS | 0.06 | 0.04 | 0.12 | -0.02 | 0.04 |
| Average Basic Shares Outstanding | 1.63B | 1.62B | 1.63B | 1.63B | 1.63B |
| Average Diluted Shares Outstanding | 1.63B | 1.62B | 1.63B | 1.63B | 1.63B |
| Dividend Per Share | 0.00 | 0.06 | -- | 0.06 | 0.00 |
| Payout Ratio | 107.16% | 94.39% | 4.61% | -237.77% | 54.02% |